
Howard Colman
Chief Resident, PGY-7
Credentials: · · · ·
History
2020–PresentHuntsman Cancer Institute & Hospital
PGY-72020–Present
- 2027–2028
Clinical Neurophysiology

1985–1989
Research
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
New England Journal of Medicine · 2015 · 2,511 citations
Cancer Cell · 2006 · 2,472 citations
A randomized trial of bevacizumab for newly diagnosed glioblastoma
New England Journal of Medicine · 2014 · 2,221 citations

32 papers

22 papers
- PW
20 papers

20 papers · 3 as a resident

19 papers

19 papers

17 papers

16 papers
Grants
- 2026–2031
Effects of Combined FAK Inhibition with MAPK Blockade in Brain Metastases from Cutaneous Melanoma
National Cancer Institute · R01
PI · $634.9K · Utah State Higher Education System--University of Utah
- 1997–2027
National Cancer Institute · P30
Project lead · $269.5K · Utah State Higher Education System--University of Utah
Clinical trials
- 2024–2030
Principal investigator · Recruiting · Phase 1, Phase 2
University of Utah
- 2023–2026
Principal investigator · Recruiting · Phase 1
Orbus Therapeutics, Inc.
- 2022–2024
Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
Study chair · Completed · Phase 1
University of California, San Francisco
- 2010–2015
Multi-Tracer PET Assessment of Primary Brain Tumors
Study chair · Completed · Phase 1
University of Utah

